Extrasynaptic GABAA Receptors

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Neuroscience, Science & Nature, Science
Cover of the book Extrasynaptic GABAA Receptors by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781493914265
Publisher: Springer New York Publication: September 22, 2014
Imprint: Springer Language: English
Author:
ISBN: 9781493914265
Publisher: Springer New York
Publication: September 22, 2014
Imprint: Springer
Language: English

GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABAA and GABAB receptors. Recently, a novel form of GABAA receptor-mediated inhibition, termed “tonic” inhibition, has been described. Whereas synaptic GABAA receptors underlie classical “phasic” GABAA receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABAA receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABAA receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This book highlights ongoing work examining the properties of recombinant and native extrasynaptic GABAA receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABAA receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABAA and GABAB receptors. Recently, a novel form of GABAA receptor-mediated inhibition, termed “tonic” inhibition, has been described. Whereas synaptic GABAA receptors underlie classical “phasic” GABAA receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABAA receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABAA receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This book highlights ongoing work examining the properties of recombinant and native extrasynaptic GABAA receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABAA receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.

More books from Springer New York

Cover of the book Neuroanatomy by
Cover of the book Posttranslational Protein Modifications in the Reproductive System by
Cover of the book Combinatorial Computational Biology of RNA by
Cover of the book Ultra Low Bit-Rate Speech Coding by
Cover of the book Essential Linear Algebra with Applications by
Cover of the book Representation Theory of Finite Groups by
Cover of the book Information Retrieval: A Health Care Perspective by
Cover of the book 3D Integration for NoC-based SoC Architectures by
Cover of the book Handbook of Psychopathology in Intellectual Disability by
Cover of the book Handbook of Evidence-Based Substance Abuse Treatment in Criminal Justice Settings by
Cover of the book From Fourier Analysis and Number Theory to Radon Transforms and Geometry by
Cover of the book Cloud Computing for Data-Intensive Applications by
Cover of the book Underemployment by
Cover of the book Bayesian Essentials with R by
Cover of the book Transporters in Drug Development by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy